Abstract
Background and objectives
Warfarin-related nephropathy is reported to occur with an INR >3.0 as a result of glomerular bleeding. There is a lack of prospective studies examining the effect of supratherapeutic warfarin anticoagulation on haematuria and acute kidney injury (AKI). Older patients may be susceptible due to greater warfarin use, prevalence of kidney disease and comorbidities. The objective of this study was to determine the incidence and nature of haematuria and AKI in older patients on warfarin and to determine any association with high INR levels.
Design, setting, participants and measurements
This was a prospective, observational study of 150 elderly patients receiving warfarin anticoagulation who were acutely hospitalised in a tertiary hospital. AKI was assessed using RIFLE criteria. Urinalysis was performed to quantify haematuria, characterise erythrocyte morphology and measure the albumin–creatinine ratio. Positive cases received follow-up at 4–6 weeks to determine resolution.
Results
An INR >3.0 was found in 54 % of patients. Pre-admission antibiotic use increased the risk of excessive anticoagulation. The incidence of isolated AKI, isolated haematuria and both was 18.7, 13.3 and 12 %, respectively. Factors associated with a higher risk of haematuria were an INR >4.0, non-urinary infection, catheterisation and albuminuria. Most cases of AKI were mild, and there was no demonstrable correlation between the admission INR and AKI. Admission with heart failure was significantly associated with an increased risk of persistent kidney impairment at follow-up.
Conclusions
Supratherapeutic warfarin anticoagulation was associated with an increased risk of haematuria, but not with AKI. The majority of cases of haematuria were transient.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Brodsky SV, Satoskar A, Chen J et al (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54(6):1121–1126
Moreno JA, Martin-Cleary C, Gutierrez E et al (2012) AKI associated with macroscopic glomerular hematuria: clinical and pathophysiologic consequences. Clin J Am Soc Nephrol 7(1):175–184
Ware K, Brodsky P, Satoskar AA et al (2011) Warfarin-related nephropathy modeled by nephron reduction and excessive anticoagulation. J Am Soc Nephrol 22(10):1856–1862
Ozcan A, Ware K, Calomeni E et al (2012) 5/6 nephrectomy as a validated rat model mimicking human warfarin-related nephropathy. Am J Nephrol 35(4):356–364
Brodsky SV, Collins M, Park E et al (2010) Warfarin therapy that results in an international normalization ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract 115(2):c142–c146
Brodsky SV, Nadasdy T, Rovin BH et al (2011) Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int 80(2):181–189
Brodsky SV, Rovin BH, Hebert LA (2012) Benefit of cyclophosphamide therapy in IgA nephritis may have been obscured by warfarin-related nephropathy in the randomized trials in which warfarin and dipyridamole were used in combination with cyclophosphamide. Nephrol Dial Transplant 27(2):475–477
Limdi NA, Beasley TM, Baird MF et al (2009) Kidney function influences warfarin responsiveness and hemorrhagic complications. J Am Soc Nephrol 20(4):912–921
Kleinow ME, Garwood CL, Clemente JL, Whittaker P (2011) Effect of chronic kidney disease on warfarin management in a pharmacist-managed anticoagulation clinic. J Manag Care Pharm 17(7):523–530
Mathew TH, Johnson DW, Jones GR (2007) Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 187(8):459–463
Ricci Z, Cruz D, Ronco C (2008) The RIFLE criteria and mortality in acute kidney injury: a systematic review. Kidney Int 73(5):538–546
Baillargeon J, Holmes HM, Lin YL et al (2012) Concurrent use of warfarin and antibiotics and the risk of bleeding in older adults. Am J Med 125(2):183–189
Glasheen JJ, Fugit RV, Prochazka AV (2005) The risk of over anticoagulation with antibiotic use in outpatients on stable warfarin regimens. J Gen Intern Med 20(7):653–656
Gutierrez E, Gonzalez E, Hernandez E et al (2007) Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy. Clin J Am Soc Nephrol 2(1):51–57
Metra M, Nodari S, Parrinello G et al (2008) Worsening renal function in patients hospitalised for acute heart failure: clinical implications and prognostic significance. Eur J Heart Fail 10(2):188–195
Freda BJ, Slawsky M, Mallidi J, Braden GL (2011) Decongestive treatment of acute decompensated heart failure: cardiorenal implications of ultrafiltration and diuretics. Am J Kidney Dis 58(6):1005–1017
Johnson SG, Rogers K, Delate T, Witt DM (2008) Outcomes associated with combined antiplatelet and anticoagulant therapy. Chest 133(4):948–954
Douketis JD (2011) Combination warfarin-ASA therapy: which patients should receive it, which patients should not, and why? Thromb Res 127(6):513–517
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lim, A.K.H., Campbell, D.A. Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation. Int Urol Nephrol 45, 561–570 (2013). https://doi.org/10.1007/s11255-012-0364-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-012-0364-0